| Bioactivity | KR-32568 is a sodium/hydrogen exchanger-1 (NHE-1) inhibitor with an IC50 of 230 nM. KR-32568 has cardioprotective effects[1][2]. |
| Target | IC50: 230 nM (NHE-1) |
| Invitro | KR-32568 (10 nM-1 μM) 以浓度依赖性方式抑制 NHE-1 介导的兔富血小板血浆细胞内酸化引起的血小板肿胀,IC50 值为 24 nM[1]。 |
| In Vivo | KR-32568(0.1-1.0 mg/kg;i.v.;一次)对大鼠发挥有效的心脏保护作用,例如减少梗塞面积,并显着减少室性早搏的总数[1]。 Animal Model: |
| Name | KR-32568 |
| CAS | 852146-73-7 |
| Formula | C13H12FN3O2 |
| Molar Mass | 261.25 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Hui-Yul Roh, et al. Cardioprotective effects of [5-(2-methyl-5-fluorophenyl)furan-2-ylcarbonyl]guanidine (KR-32568) in an anesthetized rat model of ischemia and reperfusion heart injury. Pharmacology. 2005 Dec;75(1):37-44. [2]. Sunkyung Lee, et al. (5-Arylfuran-2-ylcarbonyl)guanidines as cardioprotectives through the inhibition of Na+/H+ exchanger isoform-1. J Med Chem. 2005 Apr 21;48(8):2882-91. |